Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
June 10th, 2022
California Agency Proposes Broad Privacy Rules
Privacy & Data Security Group Chair Daniel M. Goldberg was quoted in the article, “California Agency Proposes Broad Privacy Rules” published by MediaPost. The article discusses the new rules proposed by California’s privacy regulator that aim to extend residents' ability to control how their data is shared by prohibiting businesses from selling or sharing consumers’ information for purposes unrelated to its collection, without opt-in consent.
“The new proposed regulations, combined with an explanation released Friday, appear in some circumstances to impose obligations beyond simply honoring do-not-sell-or-share requests,” according to Daniel. He says, that broad approach “threatens many business models,” adding that he expects the industry "to push back significantly."
Read full article here.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
